OrganismPart: human left ventricular myocardium  
Disease: ischaemic cardiomyopathy  
Disease: dilated cardiomyopathy  
Disease: heart failure  
Temperature: −196 °C  
Temperature: −170 to −180 °C  
AssayName: tandem liquid chromatography–mass spectrometry (LC-MS/MS)  
Instrument: Agilent (Santa Clara, CA, USA) 1260 Infinity liquid chromatography system  
Instrument: QTRAP5500 mass spectrometer (AB Sciex, Foster City, CA, USA)  
IonizationType: positive and negative ionization modes  
Separation: hydrophilic interaction chromatography  
Separation: BEH Amide column  
Compound: 8 M guanidine  
Compound: 100 mM Tris (pH 8.0)  
ReductionReagent: 10 mM tris(2-carboxyethyl)phosphine  
AlkylationReagent: 40 mM 2-chloroacetamide  
Temperature: 95 °C  
Time: 5 min  
Temperature: 4 °C  
Time: 20 min  
Temperature: −30 °C  
Time: overnight  
Compound: 100 mM Tris pH 7.5  
Compound: 10% 2,2,2-Trifluoroethanol  
CleavageAgent: sequencing grade LysC (Wako Chemicals)  
CleavageAgent: trypsin (Sigma)  
Temperature: 37 °C  
SyntheticPeptide: iRT peptides (Biognosys)  
Instrument: Dionex 3500 ultra-high performance liquid chromatography (UHPLC)  
Instrument: Q-Exactive HF-X  
IonizationType: positive polarity mode  
AcquisitionMethod: data-independent acquisition mode (DIA)  
FragmentationMethod: HCD  
NumberOfFractions: 12 concatenated fractions  
AcquisitionMethod: data-dependent acquisition (DDA)  
CollisionEnergy: 27 NCE  
PrecursorMassTolerance: 20 ppm  
FragmentMassTolerance: 20 ppm  
PrecursorMassTolerance: 4.5 ppm  
GradientTime: 60 min  
FlowRateChromatogram: 6 μl/min  
Compound: 2–40% acetonitrile containing 10 mM ammonium formate